Sponsor or institution
Clinical trials and research at Luye Pharma Group Ltd.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Luye Pharma Group Ltd. that are recruiting, in China. By phase: Phase 1 (2), Phase 3 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Multiple-dose safety and tolerability test of LY03020 in healthy adults and people with stable schizophrenia | Phase 1 | Beijing | Recruiting | Nov 17, 2025 |
| Evaluating a new medication for tardive dyskinesia | Phase 1/2 | Shanghai | Recruiting | Dec 12, 2024 |
| Comparing Lurbinectedin and Topotecan for Relapsed Small Cell Lung Cancer | Phase 3 | Jilin City | Recruiting | Jul 11, 2024 |
| Testing LPM6690176 in patients with advanced solid tumors | Phase 1 | Beijing | Recruiting | Feb 5, 2024 |
| Comparing LY01610 and Topotecan for Recurrent Small Cell Lung Cancer | Phase 3 | Beijing | Recruiting | Nov 13, 2023 |
All recruiting trials (5)
-
Multiple-dose safety and tolerability test of LY03020 in healthy adults and people with stable schizophrenia
This test will see if taking repeated oral doses of LY03020 is safe and tolerated by healthy Chinese adults and people with stable schizophrenia.
-
Evaluating a new medication for tardive dyskinesia
This study is testing a new medication for tardive dyskinesia to see if it helps people aged 18 to 65 who have had symptoms from their medication for at least three months.
-
Comparing Lurbinectedin and Topotecan for Relapsed Small Cell Lung Cancer
This study is testing if a new drug called Lurbinectedin, alone or with another medication, works better than Topotecan for people with small cell lung cancer that has come back after previous treatment.
-
Testing LPM6690176 in patients with advanced solid tumors
This study is testing a new capsule treatment for people with advanced solid tumors who have run out of other options to see if it is safe and effective.
-
Comparing LY01610 and Topotecan for Recurrent Small Cell Lung Cancer
This study is testing whether a new drug called LY01610 is better than topotecan for people with recurrent small cell lung cancer who have not responded to previous treatment.
Quick answers
How many clinical trials run by Luye Pharma Group Ltd. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 3: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.